INSU Acquisition II Debt/Equity
What is the Debt/Equity of INSU Acquisition II?
The Debt/Equity of INSU Acquisition Corp. II is -1.14
What is the definition of Debt/Equity?
Debt to equity ratio is a financial ratio indicating the relative proportion of shareholders’ equity and debt used to finance a company’s assets.
lfy (last fiscal year)
The debt to equity ratio is generally calculated by dividing debt by equity. The D/E ratio is also known as risk, gearing or leverage. The two components are often taken from the firm's balance sheet or statement of financial position (so-called book value), but the ratio may also be calculated using market values for both, if the company's debt and equity are publicly traded, or using a combination of book value for debt and market value for equity financially. Preferred stock can be considered part of debt or equity. Attributing preferred shares to one or the other is partially a subjective decision but will also take into account the specific features of the preferred shares. When used to calculate a company's financial leverage, the debt usually includes only the long-term debt.
Debt/Equity of companies in the Finance sector on NASDAQ compared to INSU Acquisition II
What does INSU Acquisition II do?
Insight Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on business in the FinTech, wealth, asset, investment management, and insurance tech sectors. Insight Acquisition Corp. was incorporated in 2021 and is based in New York, New York.
Companies with debt/equity similar to INSU Acquisition II
- International Stem Cell has Debt/Equity of -1.14
- Northwest Biotherapeutics has Debt/Equity of -1.14
- Gas2Grid has Debt/Equity of -1.14
- Eagle Graphite has Debt/Equity of -1.14
- Appili Therapeutics has Debt/Equity of -1.14
- Appili Therapeutics Inc has Debt/Equity of -1.14
- INSU Acquisition II has Debt/Equity of -1.14
- China Ocean Industry has Debt/Equity of -1.14
- Tamilnadu Telecommunications has Debt/Equity of -1.14
- Mitesco has Debt/Equity of -1.14
- Euro Sun Mining has Debt/Equity of -1.14
- Euro Sun Mining has Debt/Equity of -1.14
- Scopus Biopharma has Debt/Equity of -1.14